As said MDR has bit less potentials but EPAT could go on to catch up with RAP on some successful testing results and product upgrade and so yes believe won't be surprise to see up trading around 4-6c in a week or two. That would bring MC around $28-$43m if I ain't mistaken again
Already holding EPAT and willing to load up more upon relisting.
- Forums
- ASX - By Stock
- MNQ
- Ann: Change of Company Name-MNQ.AX
Ann: Change of Company Name-MNQ.AX, page-20
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online